Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Comprehensive Cancer Centers of Nevada

InstitutionResearch output, impact & collaborations

Comprehensive Cancer Centers of Nevada is a research organisation in Las Vegas, US. OpenAlex records 1,231 works and 73,701 citations for it. 125 researchers list it as their most recent affiliation.

1,231
Works
73,701
Citations
125
Researchers
116
Avg h-index

How has Comprehensive Cancer Centers of Nevada's publication output changed over time?

ScholarIQpublication output · 2012–2018

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2018.

1
1
1
1
1
1
201220132014201520172018

What are the most-cited papers on Comprehensive Cancer Centers of Nevada?

ScholarIQmost cited works
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae‐Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel Ángel Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald R. Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian Poehlein, Rodolfo F. Perini, Dean F. Bajorin
New England Journal of Medicine. 20173,424 CitationsOPEN ACCESS
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
Christopher J. Sweeney, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Mario A. Eisenberger, Yu-Ning Wong, Noah M. Hahn, Manish Kohli, Matthew M. Cooney, Robert Dreicer, Nicholas J. Vogelzang, Joel Picus, Daniel H. Shevrin, Maha Hussain, Jorge A. García, Robert S. DiPaola
New England Journal of Medicine. 20152,869 CitationsOPEN ACCESS
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E. Kyriakopoulos, Yu‐Hui Chen, Michael A. Carducci, Glenn Liu, David F. Jarrard, Noah M. Hahn, Daniel H. Shevrin, Robert Dreicer, Maha Hussain, Mario A. Eisenberger, Manish Kohli, Elizabeth R. Plimack, Nicholas J. Vogelzang, Joel Picus, Matthew M. Cooney, Jorge A. García, Robert S. DiPaola, Christopher J. Sweeney
Journal of Clinical Oncology. 20181,116 CitationsOPEN ACCESS
Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
Maha Hussain, Catherine M. Tangen, Donna L. Berry, Celestia S. Higano, E. David Crawford, Glenn Liu, George Wilding, Stephen M. Prescott, S.K. Sundaram, Eric J. Small, Nancy A. Dawson, Bryan Donnelly, Peter Venner, Ulka N. Vaishampayan, Paul F. Schellhammer, David I. Quinn, Derek Raghavan, Benjamin Ely, Carol M. Moinpour, Nicholas J. Vogelzang, Ian M. Thompson
New England Journal of Medicine. 2013574 CitationsOPEN ACCESS
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap, Vijay Peddareddigari, Peter F. Lebowitz, Ngocdiep T. Le, Howard A. Burris, Wells A. Messersmith, Peter J. O’Dwyer, Kevin B. Kim, Keith T. Flaherty, Johanna C. Bendell, René González, Razelle Kurzrock, Leslie A. Fecher
The Lancet Oncology. 2012545 CitationsOPEN ACCESS

How much of the research on Comprehensive Cancer Centers of Nevada is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
0%
Bronze
50%
Closed
0%

Related on ScholarIQ

Prostate Cancer Treatment and Research
Top Topic
Cancer Immunotherapy and Biomarkers
Top Topic
Radiopharmaceutical Chemistry and Applications
Top Topic
Advanced Radiotherapy Techniques
Top Topic
Renal cell carcinoma treatment
Top Topic
Bladder and Urothelial Cancer Treatments
Top Topic
470M+ articles · free account